Bullet Points from the Proactive Video
- Montefiore
Bullet Points from the Proactive Video
- Montefiore patients were very, very sick – and, amazingly, 4 survived
- However, after the Montefiore patients, 95% of patients are showing improvement
- In fact, there have been NO patient deaths after Montefiore patients
- In other words, the rate of survival with leronlimab is 100%
- Dr. Patterson found a protein in COVID that has not been talked about
- It is 100x the normal level in critical patients
- And it is 5x the normal level in mild to moderate patients
- That protein happens to be Rantes (CCL5)
- And Rantes is the specific target that leronlimab blocks
- Rantes is a like a magnet for immune cells
- There are high levels of Rantes found in the lungs, liver, and kidneys
- This explains the morbidity and mortality due to these end organ processes
- By blocking Rantes, leronlimab blocks the mass migration of immune cells which produce toxic cytokines that destroy lung tissue
- Leronlimab blocks this protein, it is the key to COVID, and it is a brand new discovery that nobody has ever talked about
- Leronlimab is the only drug in the world that quiets the cytokine storm, improves immunologic homeostasis, and decreases viral load
- No other drug can claim that
- Anthony Fauci said yesterday that the antiviral remdesivir would have to be combined with an anti-inflammatory that addresses the immunological problems
- Leronlimab is one drug that addresses the immunological issues and drops the viral load as if it was an antiviral
- We have figured out this disease
MY COMMENT: The paper will begin to be discussed tomorrow – and it is going to be big.
8
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Robotics in the Spotlight: Pudu's Grand European Entry Well, you don't see this every day—Pudu Robotics, a name riding high in the robotics sphere, is strutting its stuff over at IFA 2026 in Berlin. This ain't just a teaser, folks. They're unloading the whole toolkit, diving head-first into the European market. From gears turning in service delivery bots to industrial...
Continue Reading
Unexpected Developments from Acepodia Folks keeping a keen eye on the biotech scene might just raise an eyebrow at Acepodia's latest move. The FDA has given their nod to ACE723, an ambitious dual-payload antibody-drug conjugate (ADC) designed to wrangle with those stubborn cases of unresectable or metastatic hepatocellular carcinoma (HCC). This isn't just another day in...
Continue Reading
Agroz Surging Ahead with Global Acclaim There's a new breeze blowing through the AgTech industry, and it's carrying Agroz Inc. (NASDAQ: AGRZ) straight to the top. Fresh off the back of snagging several prestigious international awards, this vertically integrated agricultural tech powerhouse is making waves not just in Malaysia, but on the global stage. Top of the FoodTech...
Continue Reading
Mountains of Data Amid Mudslide Mayhem One flip of fate and a remote region of Nepal is left scrambling, buried under a cascade of rock and ice. The August 26 mudslide, brewed by a high-altitude glacier giving way, dug deep into the landscapes bordering China and Nepal. Now, it's a hard-nosed reality where human lives, landscapes, and diplomatic ties get tossed around....
Continue Reading
Strategic Movements in the Logistics Arena Putting wheels to brilliant moves, Planes Moving & Storage of Dayton is tweaking its operations with a big change in scenery—expect the dynamics in the Cincinnati-Dayton corridor to really start popping. Now, if you’ve ever skimmed the logistics world, you know it’s a place where shuffles can be seismic, and relocating...
Continue Reading
Labcorp's Legal Tangle Unveiled One minute you're on Labcorp's website searching for medical info, the next you're caught up in a class-action legal whirlwind. Legal drama is not on any patient’s checklist, but here we are, with Labcorp knee-deep in some serious allegations. The crux of the matter points to alleged wiretapping violations, with claims that Labcorp,...
Continue Reading
FTC Cracks Down on Hims & Hers Privacy Practices Most folks don't wake up wanting to find their investments tangled in legal drama. But here we are with Hims & Hers Health (NYSE: HIMS), facing fire from the Federal Trade Commission (FTC). They’re being called out for allegedly spilling the beans on users' sensitive health data—something they claimed to keep under...
Continue Reading
Baseus Pumps New Blood into Tech Gadgets Well, if you're looking for some fresh tech pumping in from Berlin, Baseus tossed out some intriguing gizmos at IFA 2026 that'll perk up your ears. We're looking at an evolution from a brand that's clawed its way from everyday accessories to a full-blown tech ecosystem—pretty ambitious, if you ask me. Baseus isn't playing small...
Continue Reading
Delving into Vobile's Latest Strategic Move Vobile, a heavyweight in digital content protection based out of Santa Clara, California, has hit the headlines with a new venture. They've inked a strategic cooperation and commercial agreements with Unified National Networks (UNN) of Brunei Darussalam to construct AI factories. This ain't your run-of-the-mill news, folks. It's...
Continue Reading
York Space Systems: Under Legal Fire You ever hear the one about York Space Systems? Yeah, their ticker YSS is buzzing for all the wrong reasons. Not even a year out from their IPO, and already they're tangled in a class action lawsuit that's got investors with their heads in their hands. ClaimsFiler, a shareholder information outfit, just blasted out a reminder for...
Continue Reading
Top 5 Most Recently Viewed Articles
Recent Shift in ETF Investment Trends In a surprising turn of events, a remarkable streak of inflows into the Vanguard S&P 500 ETF has come to an abrupt halt in June. Despite the S&P 500 reaching fresh all-time highs, the ETF has experienced a staggering $5.69 billion in outflows, marking the first monthly net redemption since December 2022 and the second-largest outflow...
Continue Reading
TMT Acquisition Corp (Nasdaq: TMTCU, TMTC, and TMTCR) is gearing up for some pivotal moves as it seeks to stretch its timeline for potential business combinations. This isn’t just a minor tweak; this is about laying down the groundwork that could dictate its future trajectory in the volatile waters of mergers and acquisitions. Game Plan for Extension Amendments Here’s...
Continue Reading
Lithia & Driveway (LAD) Strengthens Its Market Position Lithia & Driveway (NYSE: LAD) is making significant strides in the automotive retail sector with a recent share repurchase update and strategic acquisition plans. This initiative not only showcases their commitment to increasing shareholder value but also highlights their expansion efforts in the Canadian market....
Continue Reading
Introduction to Caisse Française de Financement Local's EMTN Issuance Caisse Française de Financement Local is embarking on an exciting journey with their latest issuance of Euro 150,000,000 Fixed Rate Obligations Foncières. This decision marks another significant step in their ongoing commitment to solidify their presence in the financial market. Details of the New...
Continue Reading
PCL Construction Shares Vision for 2026 PCL Construction Enterprises, Inc. has released its outlook for the upcoming year, illustrating the landscape of opportunities and challenges in the construction industry. The report emphasizes that while the overall commercial construction sector is predicted to see a modest growth of 2.6%, several key areas, including data...
Continue Reading